[
  {
    "ts": "2025-12-07T07:08:12+00:00",
    "headline": "What Charles River Laboratories International (CRL)'s Strengthening DSA Bookings Trend Means For Shareholders",
    "summary": "On December 3, 2025, Charles River Laboratories presented at Evercore’s 8th Annual Healthcare Conference in Coral Gables, highlighting fourth-quarter demand trends and improving Discovery and Safety Assessment (DSA) booking activity, including a steadily rising net book-to-bill ratio since the start of the third fiscal quarter. Management’s emphasis on sustained month‑by‑month improvement in DSA net book‑to‑bill, despite typical holiday season slowdowns, offers fresh insight into the...",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-crl-070812047.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "60a36623-c3f5-3c83-bb87-205136c6393f",
      "content": {
        "id": "60a36623-c3f5-3c83-bb87-205136c6393f",
        "contentType": "STORY",
        "title": "What Charles River Laboratories International (CRL)'s Strengthening DSA Bookings Trend Means For Shareholders",
        "description": "",
        "summary": "On December 3, 2025, Charles River Laboratories presented at Evercore’s 8th Annual Healthcare Conference in Coral Gables, highlighting fourth-quarter demand trends and improving Discovery and Safety Assessment (DSA) booking activity, including a steadily rising net book-to-bill ratio since the start of the third fiscal quarter. Management’s emphasis on sustained month‑by‑month improvement in DSA net book‑to‑bill, despite typical holiday season slowdowns, offers fresh insight into the...",
        "pubDate": "2025-12-07T07:08:12Z",
        "displayTime": "2025-12-07T07:08:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-crl-070812047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-crl-070812047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]